Moving the Goal Post: Multidisciplinary Management of Advanced NSCLC

Access Course


884775.jpg?interpolation=lanczos-none&resize=300:225An oncologist, a pulmonologist, and a pathologist discuss multidisciplinary management of advanced NSCLC. 

The goal of this activity is to improve knowledge of multidisciplinary care with regard to the use of immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC).

This activity is intended for hematology/oncology specialists, pulmonologists, and pathologists.



Approximate Time to Complete: 30 minutes


Credit Available: Dec. 19, 2017 - Dec. 19, 2018


Developed through a partnership between SITC and Medscape.

sitc_log_color.png      Medscape_EDU-RGB-2x-300.png
Course Objectives
Upon completion of this activity, participants will be able to:
  • Have increased knowledge regarding the individual roles of each multidisciplinary cancer care team member in treating patients with advanced lung cancer
  • Have greater competence related to appropriate use of immune checkpoint inhibitors across the continuum of care for patients with advanced non-small cell lung cancer (NSCLC)
Accreditation Council For Continuing Medical Education
AMA PRA Category 1 Credit(s)™: 0.50
American Board of Internal Medicine
ABIM MOC Part 2 Credits: 0.50